✨ Your Portfolio is fetched and updated from zerodha.
Large
Market Cap
₹1,04,457 Cr.
P/E
55.19

Key Ratios

Market cap
Market cap
1.04 L Cr
PE
PE
55.19
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
13.89
ROCE (%)
ROCE (%)
13.35
Div Yield (%)
Div Yield (%)
-
Sales
Sales
12,956 Cr
OPM (%)
OPM (%)
24.77 %
Debt to Equity
Debt to Equity
-
About
Mankind Pharma is in the Miscellaneous sector with a M.cap of 104457.00 Cr and a PE ra… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Mankind Pharma Ltd. Business

Mankind Pharma Limited is an Indian company specializing in pharmaceutical formulations and consumer healthcare products. It emphasizes quality offerings at affordable prices, successfully building several in-house brands.

Mankind Pharma major competitors are Zydus Lifesciences, Dr. Reddy's Lab, Lupin, Torrent Pharma, Cipla, Abbott India, Alkem Laboratories.
Market Cap of Mankind Pharma is ₹1,03,972 Crs.
While the median market cap of its peers are ₹99,683 Crs.

Mankind Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Mankind Pharma is 6.13 and is ranked 8 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Jul Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation May Jul Mar Jun Sep Dec Jan Mar Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material